FDA points to decline in drug review times in 1995

Am J Health Syst Pharm. 1996 Mar 1;53(5):473-4, 476. doi: 10.1093/ajhp/53.5.473.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval / legislation & jurisprudence*
  • Investigational New Drug Application
  • United States
  • United States Food and Drug Administration*